Compounds > naxagolide

Page last updated: 2024-08-24

naxagolide and levodopa

naxagolide has been researched along with levodopa in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (50.00)	18.7374
1990's	8 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Foster, AC; Hill, RG; Iversen, L; Iversen, SD; Kemp, JA; Leeson, PD; Rupniak, NM; Saywell, K; Tricklebank, MD; Williams, BJ	1
Ahlskog, JE; Bailey, PA; Miller, PM; Muenter, MD	1
Bergman, J; Madras, BK; Melia, KF; Spealman, RD	1
Coleman, RJ; Marsden, CD; Quinn, NP; Traub, M	1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ	2
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, S	1
Cedarbaum, JM; Clark, M; Green-Parsons, A; Toy, LH	1
Bondi, JV; Coleman, RJ; Hichens, M; Lange, KW; Loper, AE; Marsden, CD; Quinn, NP; Stahl, SM	1
Factor, SA; Sanchez-Ramos, JR; Weiner, WJ	1
Barter, R; Koller, WC; Vetere-Overfield, B	1
Baumann, G; Chin, L; Lieberman, A	1
Critchley, P; Grandas, F; Marsden, CD; Quinn, N; Rohan, A; Stahl, SM	1
Boyce, S; Clarke, CE; Crossman, AR; Sambrook, MA; Stahl, SM	1
Nashef, L; Rose, FC	1
Czuczwar, SJ; Löscher, W	1

Reviews

1 review(s) available for naxagolide and levodopa

Article	Year
Neurotoxin-related research: from the laboratory to the clinic. Annals of the New York Academy of Sciences, 1992, May-11, Volume: 648 Topics: Animals; Antiparkinson Agents; Dopamine Agents; Humans; Levodopa; Mice; MPTP Poisoning; Nervous System; Neurotoxins; Oxazines; Parkinson Disease, Secondary; Prodrugs; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Saimiri	1992

Trials

1 trial(s) available for naxagolide and levodopa

Article	Year
Parkinson's disease monotherapy with controlled-release MK-458 (PHNO): double-blind study and comparison to carbidopa/levodopa. Clinical neuropharmacology, 1991, Volume: 14, Issue:3 Topics: Adult; Aged; Carbidopa; Delayed-Action Preparations; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Oxazines; Parkinson Disease	1991

Other Studies

14 other study(ies) available for naxagolide and levodopa

Article	Year
Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:3 Topics: Animals; Benzazepines; Cocaine; Discrimination Learning; Dopamine Agents; Dopamine Antagonists; Levodopa; Male; Oxazines; Receptors, Dopamine; Saimiri; Time Factors	1991
Nasogastric and intravenous infusions of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:2 Topics: Adult; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Intubation, Gastrointestinal; Levodopa; Male; Middle Aged; Oxazines; Parkinson Disease; Psychomotor Performance	1990
(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Animals; Antiparkinson Agents; Athetosis; Chorea; Dopamine Agents; Levodopa; Oxazines; Saimiri	1990
Modulatory role for CCK-B antagonists in Parkinson's disease. Clinical neuropharmacology, 1990, Volume: 13, Issue:4 Topics: Animals; Benzodiazepinones; Carbidopa; Cholecystokinin; Devazepide; Dopamine Agents; Levodopa; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenylurea Compounds; Receptors, Cholecystokinin; Saimiri	1990
Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease: evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:4 Topics: Activities of Daily Living; Antiparkinson Agents; Brain; Carbidopa; Delayed-Action Preparations; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Oxazines; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2	1990
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. Neurology, 1990, Volume: 40, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxazines; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri	1990
The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4, Issue:2 Topics: Administration, Cutaneous; Adult; Antiparkinson Agents; Dopamine Antagonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Oxazines; Parkinson Disease	1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Oxazines; Parkinson Disease	1989
Tremors in early Parkinson's disease. Clinical neuropharmacology, 1989, Volume: 12, Issue:4 Topics: Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Oxazines; Parkinson Disease; Tremor	1989
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease. Clinical neuropharmacology, 1988, Volume: 11, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine	1988
Antiparkinsonian activity of a single oral dose of PHNO. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:1 Topics: Administration, Oral; Adult; Aged; Carbidopa; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Oxazines; Parkinson Disease, Secondary; Reaction Time	1987
Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Naunyn-Schmiedeberg's archives of pharmacology, 1988, Volume: 338, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Macaca fascicularis; Male; Oxazines; Parkinson Disease, Secondary; Pyridines	1988
Parkinson's disease: further steps forward. Gerontology, 1987, Volume: 33, Issue:6 Topics: Adrenal Medulla; Adult; Animals; Dementia; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurons; Oxazines; Parkinson Disease	1987
Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. European journal of pharmacology, 1986, Aug-22, Volume: 128, Issue:1-2 Topics: Animals; Anticonvulsants; Apomorphine; Female; Gerbillinae; Kindling, Neurologic; Levodopa; Lisuride; Male; Mice; Oxazines; Rats; Receptors, Dopamine; Stimulation, Chemical	1986